Metformin is associated with a reduction in the number of COVID-19 cases

Published Date: 08 Mar 2023

The latest data on metformin in COVID show benefits in the disease.

Read Full News

Latest News

HIV Care Coordination Program May Reduce Deaths in NYC

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Funding Cuts Drive Sharp Drop in HIV Prevention, UNAIDS Says

Almost 40% fewer people got a drug to help prevent HIV infection in 2025 than in the previous year, as global aid funding cuts ⁠hit preventive services particularly hard,...

Organon Wins US Approval to Widen Use Of Arthritis Biosimilar Drug

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Ebola Testing Stalled in Three Congo Labs Due to Shortages, Says WHO

Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World ⁠Health Organization said, as the outbreak of the dangerous...

Neurological Effects of Ebola Persist Years After Infection

Despite partial recovery, neurological symptoms persist for years after infection in some adult survivors of Ebola, a prospective study showed.

In Congo, Doctors Face Ebola With Little Protection

Harrowing scenes are unfolding at health facilities at the epicenter of an Ebola outbreak in the Democratic Republic of Congo.

Todays Updates

Pain’s Toll: Frailty Risk for Childhood Cancer Survivors

Pain that interferes with daily functioning is associated with higher odds of frailty and its progression in adult survivors of childhood cancer.

The Growing Role of AI in Cancer Treatment

Cancer care is becoming too complex for any one clinician to track alone, making AI an increasingly valuable tool in modern oncology.

PSA Screening May Modestly Curb Prostate Cancer Deaths

New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress the gains are modest and come with risk for overdiagnosis.

Capivasertib Wins Metastatic Prostate Cancer Approval

The CAPItello-281 trial reported a 19% improvement in radiographic progression-free survival.

Todays Updates

Pain’s Toll: Frailty Risk for Childhood Cancer Survivors

Pain that interferes with daily functioning is associated with higher odds of frailty and its progression in adult survivors of childhood cancer.

The Growing Role of AI in Cancer Treatment

Cancer care is becoming too complex for any one clinician to track alone, making AI an increasingly valuable tool in modern oncology.

PSA Screening May Modestly Curb Prostate Cancer Deaths

New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress the gains are modest and come with risk for overdiagnosis.

Capivasertib Wins Metastatic Prostate Cancer Approval

The CAPItello-281 trial reported a 19% improvement in radiographic progression-free survival.

Latest News

New York City’s revised Care Coordination Program may help reduce risks for all-cause and HIV-related deaths among people with HIV infection, including those at the highest risk for poor outcomes.

Almost 40% fewer people got a drug to help prevent HIV infection in 2025 than in the previous year, as global aid funding cuts ⁠hit preventive services particularly hard,...

Organon said on Wednesday the U.S. Food and Drug Administration has approved the expanded ⁠use of its arthritis drug, a biosimilar to Roche's Actemra, to treat a...

Three laboratories in Democratic Republic of Congo have run out of supplies to test for Ebola, the World ⁠Health Organization said, as the outbreak of the dangerous...

Despite partial recovery, neurological symptoms persist for years after infection in some adult survivors of Ebola, a prospective study showed.

Harrowing scenes are unfolding at health facilities at the epicenter of an Ebola outbreak in the Democratic Republic of Congo.

News All Time

Deep Dive: IL Inhibitor and JAK Inhibitor in Atopic Dermatitis

IL-4 and IL-13 drive the inflammation that breaks down the skin barrier and fuels the “atopic march” when atopic dermatitis (AD) progresses to other allergic diseases. Dupilumab blocks signaling through both pathways, delivering disease control that can persist even after treatment discontinuation in some patients.

US to Re-engage With Gavi Vaccine Alliance Amid Ebola Outbreak, Rubio Says

U.S. Secretary of State Marco Rubio said on Tuesday that the U.S. would re-engage with the global vaccine alliance Gavi amid the Ebola outbreak in several African...

Trump Signs Order to Use HHS Vaccine Assessment as Federal Guide

U.S. President Donald Trump signed an executive order to ⁠acknowledge a recent scientific assessment by the Department of Health and Human ⁠Services on childhood vaccines as...

Flesh-eating Screwworm Found Within 31 Miles of US Border, Says USDA

A devastating parasitic fly that eats warm-blooded animals alive and could cause millions of dollars in economic ⁠damage to the U.S. economy has been found in a young sheep...

US Regulator Approves Oral Drug From Japan's Shionogi to Prevent COVID-19

Japan's Shionogi & Co said on Monday ⁠the U.S. Food and Drug Administration has approved ⁠its oral antiviral Ensitrelvir, commercially known as ⁠Xocova, for the...

Deep Dive: Reducing CV Risk Beyond LDL in Secondary Prevention

The 2026 ACC/AHA Dyslipidemia Guideline has set a numerical LDL-C target for secondary prevention. Now what?

WHO Identifies Ebola Treatments & Vaccines for Testing

The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.

FDA Advisers Recommend COVID Vaccines Be Updated to Target Current Dominant Variant

The U.S. FDA's advisory panel recommended on Thursday that COVID-19 vaccines for 2026-2027 immunization should be updated to target ⁠the dominant XFG variant, despite some...

Medicine Renamed Many Diseases: Why Rename PCOS?

The proposed PMOS terminology reframes PCOS by emphasizing the psychological, dermatologic, reproductive, and metabolic features linked to the condition.

US CDC Seeks Staff for Ebola Screening as Outbreak Response Expands

The U.S. Centers for Disease Control and Prevention has asked staff to volunteer for urgent deployment to support ⁠Ebola screening at the country's entry points, according...

mRNA Shot Offers Efficacy for Influenza-Like Illness

In older adults, a single dose of the mRNA-1010 vaccine shows superior efficacy to the standard-dose inactivated seasonal influenza vaccine in the prevention of influenza-like illness.

Red Cross Mourns Death of Three Volunteers From Ebola

The Red Cross on Saturday paid tribute to three volunteers who ⁠are believed to have died after contracting Ebola while handling bodies.

US Adds Atlanta Area Airport for Ebola Screening, CDC Says

Americans coming back from the Democratic Republic of the Congo, ⁠Uganda or South Sudan now have a second entry point for returning ⁠to the United States, with the CDC on...

US FDA Advisers to Weigh Updating 2026-27 COVID Vaccines for XFG Variant

Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be updated to target the latest circulating XFG ⁠subvariant for the 2026-27...

Shingles Shot Shows Short-Term Safety in People With HIV

In people living with HIV, the adjuvanted recombinant subunit herpes zoster vaccine shows a favorable short-term safety and tolerability profile.

Inside an African Lab That Helped Crack the Hantavirus Outbreak

(Clarifies status of Istitut Pasteur de Dakar in paragraphs 6, 8-9)

Recommended News For You

Modified personalized cancer vaccine generates powerful immune response

June 20, 2023, Health Bulletin No. 12.

By acquiring T3 Pharma, a leader in bacterial cancer treatment, Boehringer Ingelheim broadens its offering in immunooncology.

Medical debt in collections persists after cancer diagnosis

Numerous Oncologists Are Concerned About the Cost of Genomic Testing.

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

Inner Thoughts of Leonard Bernstein, the "Maestro".

Recommended Articles For You

Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies 

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes 

Cracking the Code of Subdural Hematomas: Modern Strategies for Optimal Care 

Exploring The Causes and Consequences of Low Transferrin Saturation 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Most NMIBC Recurrences Seen in BCG-Exposed Patients

2.

Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC

3.

Novel radiotracer identifies biomarker for triple-negative breast cancer

4.

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

5.

Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Method

1.

Subchorionic Hematoma: Causes, Symptoms, and Treatment 

2.

Early Detection of Breast Cancer: Signs, Symptoms, and Screening Methods

3.

Advanced Practices in Hematology in Daily Practice

4.

Polycythemia Vera: A Historical Perspective and Contemporary Management

5.

PARP Inhibitors in Testicular Cancer: Tackling Cisplatin Resistance with Precision

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

2.

From Relapse to Remission Mapping the Treatment Journey in Adult R R B Cell ALL The Critical Goal of MRD

3.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

5.

What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot